Antitumor drug
Showing all 7 results
-
Research Report on China’s Gefitinib Market, 2021-2025
$2600 – $3900 Select options -
Research Report on China’s Exemestane Market, 2021-2025
$2600 – $3900 Select options -
Research Report on China’s Lobaplatin Market, 2021-2025
$2600 – $3900 Select options -
Research Report on China’s Alectinib Market, 2021-2025
$2600 – $3900 Select options -
Research Report on China’s Sorafenib Market, 2021-2025
$2600 – $3900 Select options -
Research Report on China’s Anastrozole Market, 2021-2025
$2600 – $3900 Select options -
Investigation Report on China’s Capecitabine Market 2021-2025
$2600 – $3900 Select options